Another study showed that HER2 intratumoral heterogeneity was also more frequent in HER2-low cases than in HER2-positive cases, and those authors emphasized that smaller tumor samples are more prone to inaccurate assessment of HER2 status [23]. The gene discussed is ERBB2; the disease is neoplasm.